Clinical choices in tackling the risk of hyperkalaemia

Back

Open Access

Clinical choices in tackling the risk of hyperkalaemia

Session: Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy

Topic: Chronic Heart Failure

Speaker: Doctor M. Kosiborod (Kansas City, US) Doctor S. Zieroth (Winnipeg, CA) Doctor A. Wong (Bridgend, GB)

Sponsored by PACE-CME - Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speakers

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

55 presentations

9 followers

Doctor Shelley Zieroth

University of Manitoba, Winnipeg (Canada)

55 presentations

3 followers

Doctor Aaron K F Wong

Princess of Wales Hospital, Bridgend (United Kingdom of Great Britain & Northern Ireland)

5 presentations

1 follower

4 more presentations in this session

Introduction and a clinical case of a patient with HFrEF

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access

Slides

Video

The key role of RAASi-based therapy in symptomatic heart failure

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Access

Slides

Video

A practical model for optimising RAASi-based therapy

Speaker: Doctor A. Wong (Bridgend, GB)

Access

Slides

Video

Summary and conclusions

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access

Slides

Video

Access the full session

Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy

Speakers: Doctor M. Kosiborod, Doctor S. Zieroth, Doctor A. Wong, Doctor M. Kosiborod, Doctor S. Zieroth...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources